Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial KATP channel

European Journal of Pharmacology

Volumn 751, Issue , 2015, Pages 89-98

  Zhao, Zhifang ^a   Cui, Wei ^a   Zhang, Hailin ^a   Gao, Haixia ^a   Li, Xuze ^a   Wang, Yuanyuan ^a   Hu, Haijuan ^a   Li, Bo ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Viral Disease Control and Prevention   (China)

Author keywords

Atorvastatin; Cardioprotection; Ischaemic pre conditioning; KATP channels; Mitochondrial; Mitochondrial permeability transition pore

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ATORVASTATIN; LACTATE DEHYDROGENASE; LONIDAMINE; REACTIVE OXYGEN METABOLITE; CALCIUM; CARDIOTONIC AGENT; CARRIER PROTEIN; GLUCOSE; MITOCHONDRIAL K(ATP) CHANNEL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OXYGEN; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART HEMODYNAMICS; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LACTATE DEHYDROGENASE BLOOD LEVEL; LOADING DRUG DOSE; MALE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; NEWBORN; NONHUMAN; PHASE TRANSITION; RAT; REPERFUSION INJURY; RISK ASSESSMENT; SINGLE DRUG DOSE; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HEART INFARCTION; HEART VENTRICLE; HEMODYNAMICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; RISK;

ANIMALS; ATORVASTATIN CALCIUM; CALCIUM; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HEART VENTRICLES; HEMODYNAMICS; L-LACTATE DEHYDROGENASE; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXYGEN; POTASSIUM CHANNELS; RATS; REACTIVE OXYGEN SPECIES; RISK;

EID: 84923180985     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.01.036     Document Type: Article

References (35)

1. N. Bao, S. Minatoguchi, H. Kobayashi, S. Yasuda, I. Kawamura, M. Iwasa, T. Yamaki, S. Sumi, Y. Misao, M. Arai, K. Nishigaki, G. Takemura, T. Fujiwara, and H. Fujiwara Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits Circ. J. 71 2007 1622 1628
2. Y. Birnbaum, Y. Lin, Y. Ye, R. Merla, J.R. Perez-Polo, and B.F. Uretsky Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat J. Cardiovasc. Pharmacol. Ther. 13 2008 72 79
3. S.M. Davidson, D.M. Yellon, M.P. Murphy, and M.R. Duchen Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation Cardiovasc. Res. 93 2012 445 453
4. E.N. Dedkova, and L.A. Blatter Measuring mitochondrial function in intact cardiac myocytes J. Mol. Cell. Cardiol. 52 2012 48 61
5. L.F. Di, and M. Ziegler Pathophysiological relevance of mitochondria in NAD(+) metabolism FEBS Lett. 492 2001 4 8
6. F. Domoki, B. Kis, T. Gaspar, J.A. Snipes, F. Bari, and D.W. Busija Rosuvastatin induces delayed preconditioning against l-glutamate excitotoxicity in cultured cortical neurons Neurochem. Int. 56 2010 404 409
7. J.M. Downey, A.M. Davis, and M.V. Cohen Signaling pathways in ischemic preconditioning Heart Fail. Rev. 12 2007 181 188
8. J.C. Fantinelli, N.I.A. Perez, A.L.F. Gonzalez, G.R. Schinella, and S.M. Mosca Participation of mitochondrial permeability transition pore in the effects of ischemic preconditioning in hypertrophied hearts: role of NO and mitoKATP Int. J. Cardiol. 166 2013 173 180
9. R.A. Forbes, C. Steenbergen, and E. Murphy Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism Circ. Res. 88 2001 802 809
10. K.D. Garlid, A.D. Costa, C.L. Quinlan, S.V. Pierre, and S.P. Dos Cardioprotective signaling to mitochondria J. Mol. Cell. Cardiol. 46 2009 858 866
11. E.J. Griffiths, and A.P. Halestrap Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem. J. 307 1995 93 98
12. D.J. Hausenloy, H.L. Maddock, G.F. Baxter, and D.M. Yellon Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc. Res. 55 2002 534 543
13. M. Iguchi, M. Kato, J. Nakai, T. Takeda, M. Matsumoto-Ida, T. Kita, T. Kimura, and M. Akao Direct monitoring of mitochondrial calcium levels in cultured cardiac myocytes using a novel fluorescent indicator protein, GCaMP2-mt Int. J. Cardiol. 158 2012 225 234
14. S.P. Jones, Y. Teshima, M. Akao, and E. Marban Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes Circ. Res. 93 2003 697 699
15. T. Kuzuya, S. Hoshida, N. Yamashita, H. Fuji, H. Oe, M. Hori, T. Kamada, and M. Tada Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia Circ. Res. 72 1993 1293 1299
16. D.J. Lefer, and D.N. Granger Oxidative stress and cardiac disease Am. J. Med. 109 2000 315 323
17. W.E. Louch, K.A. Sheehan, and B.M. Wolska Methods in cardiomyocyte isolation, culture, and gene transfer J. Mol. Cell. Cardiol. 51 2011 288 298
18. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation. 74 1986 1124 1136
19. L. Nafasi, R. Rahmani, A. Shafiee, A. Salari, A. Abdollahi, and A. Meysamie High reloading dose of atorvastatin prior to percutaneous coronary intervention can reduce periprocedural myocardial infarction Curr. Med. Res. Opin. 2013 10.1185/03007995.2013.834249
20. G.A. Ngoh, L.J. Watson, H.T. Facundo, and S.P. Jones Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes Amino Acids. 40 2011 895 911
21. V. Piriou, P. Chiari, O. Gateau-Roesch, L. Argaud, D. Muntean, D. Salles, J. Loufouat, P.Y. Gueugniaud, J.J. Lehot, and M. Ovize Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition Anesthesiology. 100 2004 581 588
22. K.G. Rajesh, S. Sasaguri, Z. Zhitian, R. Suzuki, R. Asakai, and H. Maeda Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression Cardiovasc. Res. 59 2003 297 307
23. S. Roth, J.C. Dreixler, A.R. Shaikh, K.H. Lee, and V. Bindokas Mitochondrial potassium ATP channels and retinal ischemic preconditioning Investig. Ophthalmol. Vis. Sci. 47 2006 2114 2124
24. R. Salie, J.A. Moolman, and A. Lochner The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation Basic Res. Cardiol. 107 2012 281
25. S. Shanmuganathan, D.J. Hausenloy, M.R. Duchen, and D.M. Yellon Mitochondrial permeability transition pore as a target for cardioprotection in the human heart Am. J. Physiol. Heart Circ. Physiol. 289 2005 H237 H242
26. G.Q. Sun, J. Wang, Q. Li, Z.G. Ye, and Q. Xia Mitochondrial pores modulate the protective effect of acetylcholine on ventricular myocytes during ischemia/reperfusion injury Methods Find. Exp. Clin. Pharmacol. 32 2010 107 112
27. T. Takeda, M. Akao, M. Matsumoto-Ida, M. Kato, H. Takenaka, Y. Kihara, T. Kume, A. Akaike, and T. Kita Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes J. Am. Coll. Cardiol. 47 2006 1882 1890
28. L.C. Thuc, Y. Teshima, N. Takahashi, Y. Nagano-Torigoe, K. Ezaki, K. Yufu, M. Nakagawam, M. Hara, and T. Saikawa Mitochondrial K(ATP) channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection Apoptosis. 15 2010 669 678
29. K. Viswanath, S. Bodiga, V. Balogun, A. Zhang, and V.L. Bodiga Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia/reoxygenation Biometals. 24 2011 171 180
30. M. Wasilewski, M.R. Wieckowski, D. Dymkowska, and L. Wojtczak Effects of N-acylethanolamines on mitochondrial energetics and permeability transition Biochim. Biophys. Acta. 1657 2004 151 163
31. Q. Wu, H. Li, Y. Wu, W. Shen, L. Zeng, H. Cheng, and L. He Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes J. Ethnopharmacol. 138 2011 34 39
32. J. Yang, X.D. Zhang, J. Yang, J.W. Ding, Z.Q. Liu, S.G. Li, and R. Yang The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4 Mol. Biol. Rep. 38 2011 3037 3044
33. Z.Y. Zhao, P. Luan, S.X. Huang, S.H. Xiao, J. Zhao, B. Zhang, B.B. Gu, R.B. Pi, and J. Liu Edaravone protects HT22 neurons from H(2) O(2) -induced apoptosis by inhibiting the MAPK signaling pathway CNS Neurosci. Ther. 19 2013 163 169
34. J. Zhu, M.J. Rebecchi, P.S. Glass, P.R. Brink, and L. Liu Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation Am. J. Physiol. Heart Circ. Physiol. 300 2011 H922 H930
35. J.R. Zhu, Y.F. Tao, S. Lou, and Z.M. Wu Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells Acta Pharmacol. Sin. 31 2010 273 280